Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

National Medicare Education Week: The history of Medicare Part D

By Tom Wilbur  |    September 15, 2020
Today, in honor of National Medicare Education Week, we’ll be taking a quick look back at the history of Medicare, specifically the Medicare Part D prescription drug benefit .   Read More

How Medicare Part D supports patients

By Tom Wilbur  |    September 1, 2020
Since 2006, Medicare Part D has offered seniors and people living with disabilities affordable access to life-saving treatments through comprehensive prescription drug coverage. The benefit has...   Read More

Supporting access to vaccines for Part D beneficiaries

By Tom Wilbur  |    August 12, 2020
Today, in honor of National Immunization Awareness Month, we’ll take a look at how Medicare Part D supports access to critical vaccines and strengthens public health. Vaccines represent some of...   Read More

Medicare’s 55th anniversary: Celebrating the success of Part D

By Tom Wilbur  |    July 30, 2020
Today, we are excited to bring you a special edition of our Medicare Catalyst series in honor of Medicare’s 55th anniversary. On this date in 1965, President Lyndon B. Johnson signed into law...   Read More

Three reasons why MedPAC’s latest Part D proposal would be bad for patients

By Tom Wilbur  |    July 14, 2020
The recently released Medicare Payment Advisory Commission’s (MedPAC) report to Congress recommends restructuring the Medicare Part D benefit and allowing plans greater flexibility to implement...   Read More

PhRMA submits comments on CMS’s Part D specialty tier proposal

By Tom Wilbur  |    April 7, 2020
Yesterday, PhRMA submitted comments on a Centers for Medicare & Medicaid Services (CMS) proposed rule on policy and technical changes to Medicare Part D and Medicare Advantage.   Read More

Three reasons the Senate Finance package is the wrong approach for patients

By Tom Wilbur  |    August 26, 2019
For more than a decade, Medicare Part D has successfully provided seniors and people with disabilities comprehensive prescription drug coverage, while its unique market-based structure has kept...   Read More

Three things to know about the Part D GAO report

By Nicole Longo  |    August 16, 2019
The Government Accountability Office (GAO) recently released a new report looking at Medicare Part D and the role of Pharmacy Benefit Managers (PBMs) in the program. While the report provides a...   Read More

No matter how you structure it, government arbitration is wrong for Medicare drug coverage

By Nicole Longo  |    June 27, 2019
Despite concerns from a broad group of stakeholders, some in Washington continue to push for imposing government arbitration on Medicare drug coverage to set the price of a medicine....   Read More

What you should know: Government arbitration is the wrong way to change Medicare

By Juliet Johnson  |    June 10, 2019
As Washington looks to make changes to Medicare, there are right ways and wrong ways to address the challenges patients face. In recent weeks, policymakers have discussed imposing government...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates